| pubmed-article:10780061 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10780061 | lifeskim:mentions | umls-concept:C0007097 | lld:lifeskim |
| pubmed-article:10780061 | lifeskim:mentions | umls-concept:C0596473 | lld:lifeskim |
| pubmed-article:10780061 | lifeskim:mentions | umls-concept:C0543478 | lld:lifeskim |
| pubmed-article:10780061 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
| pubmed-article:10780061 | lifeskim:mentions | umls-concept:C1522609 | lld:lifeskim |
| pubmed-article:10780061 | lifeskim:mentions | umls-concept:C1554112 | lld:lifeskim |
| pubmed-article:10780061 | pubmed:dateCreated | 2000-6-8 | lld:pubmed |
| pubmed-article:10780061 | pubmed:abstractText | To evaluate and compare the performances of FDG-PET imaging, MRI and clinical examination in the detection of residual tumour 3 months after treatment of patients with head and neck squamous cell carcinoma. | lld:pubmed |
| pubmed-article:10780061 | pubmed:language | fre | lld:pubmed |
| pubmed-article:10780061 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780061 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10780061 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780061 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10780061 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10780061 | pubmed:issn | 0250-5525 | lld:pubmed |
| pubmed-article:10780061 | pubmed:author | pubmed-author:BeckerMM | lld:pubmed |
| pubmed-article:10780061 | pubmed:author | pubmed-author:LehmannWW | lld:pubmed |
| pubmed-article:10780061 | pubmed:author | pubmed-author:AllalAA | lld:pubmed |
| pubmed-article:10780061 | pubmed:author | pubmed-author:HaenggeliC... | lld:pubmed |
| pubmed-article:10780061 | pubmed:author | pubmed-author:BangPP | lld:pubmed |
| pubmed-article:10780061 | pubmed:author | pubmed-author:SlosmanDD | lld:pubmed |
| pubmed-article:10780061 | pubmed:author | pubmed-author:GuyotJ PJP | lld:pubmed |
| pubmed-article:10780061 | pubmed:author | pubmed-author:DulguerovPP | lld:pubmed |
| pubmed-article:10780061 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10780061 | pubmed:volume | 116 | lld:pubmed |
| pubmed-article:10780061 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10780061 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10780061 | pubmed:pagination | 8S-11S | lld:pubmed |
| pubmed-article:10780061 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:meshHeading | pubmed-meshheading:10780061... | lld:pubmed |
| pubmed-article:10780061 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10780061 | pubmed:articleTitle | [Value of positron emission tomography with 18-fluorodeoxyglucose (FDG-PET) in early detection of residual tumor in oro-pharyngeal-laryngeal carcinoma]. | lld:pubmed |
| pubmed-article:10780061 | pubmed:affiliation | Clinique et policlinique d'otorhinolaryngologie et de chirurgie cervico-faciale, Hôpitaux Universitaires de Genève. | lld:pubmed |
| pubmed-article:10780061 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10780061 | pubmed:publicationType | English Abstract | lld:pubmed |
| pubmed-article:10780061 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
